全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Diagnosis and Treatment of Trauma Induced Coagulopathy (TIC) Using Thromboelastography (TEG)

DOI: 10.4236/ojem.2025.131009, PP. 84-89

Keywords: Trauma Induced Coagulopathy (TIC), Thromboelastography (TEG), Fibrinogen, Tranexamic Acid (TXA), Recombinant Factor VII (rFVIIa)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Trauma induced coagulopathy (TIC) has been recognized as a distinct entity associated with increased mortality, morbidity and transfusion requirements. Uncontrolled bleeding is the most frequent preventable cause of death in trauma patients reaching hospital alive. TIC has been long thought to develop as a result of hemodilution, acidosis and hypothermia often related to resuscitation practices. The lack of well defined diagnosis criteria for TIC impedes early identification and treatment. Most authors established the presence of TIC if Prothombin time (PT) and activated thromboplastin time (APTT) were 1.5 times over the normal value. Mechanisms contributing to TIC include anticoagulation, consumption, platelet dysfunction and hyperfibrinolysis. Thromboelastography (TEG) is a portable bedside device that gives qualitative results for coagulation function, based on clotting, kinetics, strength and lysis. The result is available within 3 - 10 minutes, in the form of curve. Depending on the results of TEG, early administration of tranexamic acid (TXA), recombinant factor VIIa and aggressive blood product transfusional management for TIC with a red blood cell:plasma:platelets ratio close to 1:1:1 could result in decreased mortality from uncontrolled bleeding. This article reviews the pathophysiology and management of TIC.

References

[1]  Mathers, C.D. and Loncar, D. (2006) Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLOS Medicine, 3, e442.
https://doi.org/10.1371/journal.pmed.0030442
[2]  Brohi, K., Singh, J., Heron, M. and Coats, T. (2003) Acute Traumatic Coagulopathy. The Journal of Trauma: Injury, Infection, and Critical Care, 54, 1127-1130.
https://doi.org/10.1097/01.ta.0000069184.82147.06
[3]  Cap, A.P., Baer, D.G., Orman, J.A., Aden, J., Ryan, K. and Blackbourne, L.H. (2011) Tranexamic Acid for Trauma Patients: A Critical Review of the Literature. Journal of Trauma: Injury, Infection & Critical Care, 71, S9-S14.
https://doi.org/10.1097/ta.0b013e31822114af
[4]  Hauser, C.J., Boffard, K., Dutton, R., Bernard, G.R., Croce, M.A., Holcomb, J.B., et al. (2010) Results of the CONTROL Trial: Efficacy and Safety of Recombinant Activated Factor VII in the Management of Refractory Traumatic Hemorrhage. Journal of Trauma: Injury, Infection & Critical Care, 69, 489-500.
https://doi.org/10.1097/ta.0b013e3181edf36e
[5]  Hayakawa, M., Gando, S., Ono, Y., Wada, T., Yanagida, Y. and Sawamura, A. (2015) Fibrinogen Level Deteriorates before Other Routine Coagulation Parameters and Massive Transfusion in the Early Phase of Severe Trauma: A Retrospective Observational Study. Seminars in Thrombosis and Hemostasis, 41, 35-42.
https://doi.org/10.1055/s-0034-1398379
[6]  Rossaint, R., Bouillon, B., Cerny, V., Coats, T.J., Duranteau, J., Fernández-Mondéjar, E., et al. (2010) Management of Bleeding Following Major Trauma: An Updated European Guideline. Critical Care, 14, R52.
https://doi.org/10.1186/cc8943
[7]  Armand, R. and Hess, J.R. (2003) Treating Coagulopathy in Trauma Patients. Transfusion Medicine Reviews, 17, 223-231.
https://doi.org/10.1016/s0887-7963(03)00022-1
[8]  Borgman, M.A., Spinella, P.C., Perkins, J.G., Grathwohl, K.W., Repine, T., Beekley, A.C., et al. (2007) The Ratio of Blood Products Transfused Affects Mortality in Patients Receiving Massive Transfusions at a Combat Support Hospital. Journal of Trauma: Injury, Infection & Critical Care, 63, 805-813.
https://doi.org/10.1097/ta.0b013e3181271ba3
[9]  Schöchl, H., Maegele, M., Solomon, C., Görlinger, K. and Voelckel, W. (2012) Early and Individualized Goal-Directed Therapy for Trauma-Induced Coagulopathy. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 20, Article No. 15.
https://doi.org/10.1186/1757-7241-20-15
[10]  Whiting, P., Al, M., Westwood, M., Ramos, I.C., Ryder, S., Armstrong, N., et al. (2015) Viscoelastic Point-of-Care Testing to Assist with the Diagnosis, Management and Monitoring of Haemostasis: A Systematic Review and Cost-Effectiveness Analysis. Health Technology Assessment, 19, 1-228.
https://doi.org/10.3310/hta19580
[11]  Lier, H., Böttiger, B.W., Hinkelbein, J., Krep, H. and Bernhard, M. (2011) Coagulation Management in Multiple Trauma: A Systematic Review. Intensive Care Medicine, 37, 572-582.
https://doi.org/10.1007/s00134-011-2139-y
[12]  Haas, T., Fries, D., Tanaka, K.A., Asmis, L., Curry, N.S. and Schöchl, H. (2015) Usefulness of Standard Plasma Coagulation Tests in the Management of Perioperative Coagulopathic Bleeding: Is There Any Evidence? British Journal of Anaesthesia, 114, 217-224.
https://doi.org/10.1093/bja/aeu303
[13]  Gonzalez, E., Moore, E.E., Moore, H.B., Chapman, M.P., Chin, T.L., Ghasabyan, A., et al. (2016) Goal-Directed Hemostatic Resuscitation of Trauma-Induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays. Annals of Surgery, 263, 1051-1059.
https://doi.org/10.1097/sla.0000000000001608

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133